To support advances in the understanding of pathophysiology and therapies of kidney diseases by creating a BioBank of kidney tissue, DNA, plasma, and urine from patients with kidney diseases.
A biorepository of human samples to support research to advance understanding of human kidney diseases will be created. Clinically, kidney diseases are detected by blood and urine laboratory tests. However, the underlying cause of kidney disease is often not clear on blood and urine tests. In such cases, a clinician may choose to perform a kidney biopsy to establish the diagnosis. Patients who are scheduled to undergo a kidney biopsy will be invited to participate in this proposed study.
Study Type
OBSERVATIONAL
Enrollment
1,000
Yale New Haven Hospital, York Street Campus
New Haven, Connecticut, United States
Yale New Haven Hospital Saint Raphael Campus
New Haven, Connecticut, United States
Histological diagnosis
Histological diagnosis of kidney disease determined by evaluation by renal pathologists
Time frame: 5 years
Occurrence of chronic kidney disease, end stage kidney disease or death
Track outcomes in participants recruited for up to 10 years
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.